These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20153935)

  • 1. A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys.
    Vallender EJ; Rüedi-Bettschen D; Miller GM; Platt DM
    Drug Alcohol Depend; 2010 Jun; 109(1-3):252-6. PubMed ID: 20153935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.
    Barr CS; Chen SA; Schwandt ML; Lindell SG; Sun H; Suomi SJ; Heilig M
    Biol Psychiatry; 2010 Jan; 67(1):78-80. PubMed ID: 19748082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice.
    Bilbao A; Robinson JE; Heilig M; Malanga CJ; Spanagel R; Sommer WH; Thorsell A
    Biol Psychiatry; 2015 May; 77(10):850-8. PubMed ID: 25442002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment.
    Kranzler HR; Armeli S; Covault J; Tennen H
    Addict Biol; 2013 Jan; 18(1):193-201. PubMed ID: 22784013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.
    Henderson-Redmond AN; Lowe TE; Tian XB; Morgan DJ
    Brain Res Bull; 2018 Apr; 138():12-19. PubMed ID: 28780411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.
    Hartwell EE; Feinn R; Morris PE; Gelernter J; Krystal J; Arias AJ; Hoffman M; Petrakis I; Gueorguieva R; Schacht JP; Oslin D; Anton RF; Kranzler HR
    Addiction; 2020 Aug; 115(8):1426-1437. PubMed ID: 31961981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of morphine and naltrexone on oral ethanol self-administration in rhesus monkeys.
    Williams KL; Kane EC; Woods JH
    Behav Pharmacol; 2001 Sep; 12(5):325-33. PubMed ID: 11710747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
    Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
    Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.
    Bujarski S; MacKillop J; Ray LA
    Exp Clin Psychopharmacol; 2012 Jun; 20(3):181-90. PubMed ID: 22429255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.
    Setiawan E; Pihl RO; Benkelfat C; Leyton M
    Pharmacogenomics; 2012 Jul; 13(10):1161-72. PubMed ID: 22909206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques.
    Barr CS; Schwandt M; Lindell SG; Chen SA; Goldman D; Suomi SJ; Higley JD; Heilig M
    Arch Gen Psychiatry; 2007 Mar; 64(3):369-76. PubMed ID: 17339526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
    Anton RF; Voronin KK; Randall PK; Myrick H; Tiffany A
    Alcohol Clin Exp Res; 2012 Nov; 36(11):2000-7. PubMed ID: 22551036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
    Anton RF; Oroszi G; O'Malley S; Couper D; Swift R; Pettinati H; Goldman D
    Arch Gen Psychiatry; 2008 Feb; 65(2):135-44. PubMed ID: 18250251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats.
    Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2001 Jan; 25(1):25-33. PubMed ID: 11198711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of naltrexone on acute tolerance to ethanol in UChB rats.
    Quintanilla ME; Tampier L
    Alcohol; 2000 Jul; 21(3):245-9. PubMed ID: 11091028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence.
    Coller JK; Cahill S; Edmonds C; Farquharson AL; Longo M; Minniti R; Sullivan T; Somogyi AA; White JM
    Pharmacogenet Genomics; 2011 Dec; 21(12):902-5. PubMed ID: 21946895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys.
    Williams KL; Winger G; Pakarinen ED; Woods JH
    Psychopharmacology (Berl); 1998 Sep; 139(1-2):53-61. PubMed ID: 9768542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
    Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
    Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The μ-opioid receptor and treatment response to naltrexone.
    Thorsell A
    Alcohol Alcohol; 2013; 48(4):402-8. PubMed ID: 23543091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.